Bruno Joseph Battistini

Title: Bruno Joseph Battistini: Innovator in Cancer Treatment

Introduction

Bruno Joseph Battistini is a notable inventor based in Orford, CA. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the use of selective bradykinin B1 receptor antagonists for treating bone and prostate cancer.

Latest Patents

Bruno Joseph Battistini holds a patent for a method of treating bone or prostate cancer with selective bradykinin B1 receptor antagonists. The patent describes a specific formula for a bradykinin B1 receptor antagonist, which includes various amino acids and their derivatives. This method aims to provide effective treatment for metastases, cancers, and chemotherapy-induced neuropathies by administering the compound to patients in need.

Career Highlights

Throughout his career, Battistini has demonstrated a commitment to advancing medical science. His innovative approach to cancer treatment has garnered attention in the research community. He is associated with the company Société de Commercialisation des Produits de la Recherche Appliquée, known as Socpra Sciences Santé et Humaines S.E.C.

Collaborations

Bruno Joseph Battistini has collaborated with notable colleagues, including François Nantel and Roger Chammas. These partnerships have contributed to the development and refinement of his patented methods.

Conclusion

Bruno Joseph Battistini's work in cancer treatment exemplifies the impact of innovation in medicine. His patented methods offer hope for improved therapies for patients suffering from serious conditions.